Learning the lessons of the COVID-19 vaccine rollout
Michael Spence At this point in the pandemic, the key question is whether vaccine production can be ramped up quickly enough to allow most people to be vaccinated relatively soon. But implicit in that question is another: Whether and under what circumstances it is appropriate to suspend domestic and internationally agreed intellectual property (IP) rights. […]
Read More